Product Information
BROMPHEN-PSE-DM 2-30-10 MG/5 ML is a generic product labeled by Chartwell RX LLC, priced at $0.0804 per ML under NDC 62135030248. Its NADAC has been published 177 times since Apr 5, 2023.
FDA first approved this application on Apr 17, 2020. Its Orange Book therapeutic-equivalence code is AA.
BROMPHEN-PSE-DM 2-30-10 MG/5 ML
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan HydrobromideStrength
2; 10; 30 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Chartwell RX LLCNDC
62135030248
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213125FDA Approved
4/17/2020
TE Code
AA
On Market Since
4/17/2020
Pharmacological Classes
Price Statistics
The NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has been published 177 times since Apr 5, 2023, and over the history we have for it it has declined 20.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0804 per ML |
|---|---|
| All-time high | $0.1194 (Dec 13, 2023) |
| All-time low | $0.0594 (Apr 17, 2024) |
| 52-week high | $0.0868 |
| 52-week low | $0.0744 |
| Median price | $0.0828 |
| Average price | $0.0851 |
| Largest weekly change | +60.3% (Nov 22, 2023) |
| Weeks tracked | 177 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for BROMPHEN-PSE-DM 2-30-10 MG/5 ML, manufactured by Chartwell RX LLC, is $0.0804 per ML (NDC 62135030248), effective Aug 19, 2026.
How has the price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML changed over time?
Over the history we have for it, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has declined 20.6%. It has been tracked across 177 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
Since Apr 5, 2023, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has ranged from a low of $0.0594 (Apr 17, 2024) to a high of $0.1194 (Dec 13, 2023), with a median of $0.0828 per ML.
Are there cheaper alternatives to BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BROMPHEN-PSE-DM 2-30-10 MG/5 ML, is $0.0714 per ML — about 11% below BROMPHEN-PSE-DM 2-30-10 MG/5 ML.
Who manufactures BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
BROMPHEN-PSE-DM 2-30-10 MG/5 ML (NDC 62135030248) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.